• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Nuclear RNA export factor 5 (NXF5)

ACP19128

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP19128 Target NameNXF5
Target SynonymsNXF5; TAPL1; Nuclear RNA export factor 5; TAP-like protein 1; TAPL-1FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-397
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9H1B4
Background Information
  • Uniprot Id

    Q9H1B4

  • Target Species

    Human

  • Target Name

    NXF5

  • Target Full Name

    Nuclear RNA export factor 5

  • Target Function

    Could be involved in the export of mRNA from the nucleus to the cytoplasm. Could also have a role in polarized cytoplasmic transport and localization of mRNA in neurons.

  • Target Involvement

    A chromosomal aberration involving NXF5 has been observed in one patient with a syndromic form of mental retardation and short stature. Pericentric inversion inv(X)(p21.1;q22) that interrupts NXF5.

  • Target Subcellular Location

    Cytoplasm. Nucleus. Note=Mainly localized in the cytoplasm of cells and more particularly in the cell body and neurites of hippocampal neurons. Although nuclear localization is also observed. Not detected at nuclear rim.

  • Target Protein Families

    NXF family

  • Target Synonyms

    NXF5; TAPL1; Nuclear RNA export factor 5; TAP-like protein 1; TAPL-1

Inquire Recombinant Human Nuclear RNA export factor 5 (NXF5) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification